2 Sources
[1]
DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
Healthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy Services DataMeds AI, Inc . (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure
[2]
DataMeds AI Stock Surges on Mobile App Launch - DataMEDS AI (NASDAQ:MEDS)
DataMeds AI Inc. (NASDAQ:MEDS) shares are surging Monday morning following the launch of its "Health Lives Here" mobile application, a joint initiative with Tollo Health and the NFL Alumni Association. Here's what investors need to know. * DataMEDS AI shares are powering higher. Why are MEDS
Share
Copy Link
DataMeds AI and Tollo Health have launched the Health Lives Here mobile application in partnership with NFL Alumni Health. The app integrates telemedicine services, pharmacy services, and an AI health coach, initially targeting GLP-1 medication users with plans to expand to Long COVID and cancer patients by 2026.
DataMeds AI (NASDAQ:MEDS) has partnered with Tollo Health and NFL Alumni Health to launch the Health Lives Here mobile application, marking a significant expansion of the company's healthcare technology offerings
1
. The app initially targets users of GLP-1 receptor agonist medications, with plans to extend services to patients with Long COVID in the fourth quarter of 2026, followed by cancer patients1
. The launch coincides with the creation of a national Health Lives Here healthcare network, beginning with Moose Pharmacy of Concord in Concord, NC, selected from DataMeds' wholly-owned subsidiary Corexa Health's independent pharmacy network of over 6,500 locations1
.
Source: Benzinga
DataMeds AI shares surged 31.83% to $4.10 following the announcement, reflecting investor enthusiasm for the company's expansion into integrated digital health services
2
. The mobile application represents a strategic move to consolidate telemedicine services, pharmacy services, and health data tracking into a single platform accessible to patients nationwide2
.The Health Lives Here app provides in-app access to both asynchronous and synchronous consultations with licensed physicians who can evaluate patients for, prescribe, and help manage GLP-1 therapies where clinically appropriate
1
. Corexa Health's pharmacy offers cash-pay options to purchase FDA-approved branded GLP-1 receptor agonist medications within the app, with direct delivery to patients' homes1
. Patients can also transfer prescriptions from other pharmacies or route them to a local pharmacy of their choosing, providing flexibility in how they access medications1
.The app centers on behavioral health and personalized habit-building, featuring an AI health coach, activity logs, and an AI chatbot designed to recognize crisis language and direct users to the 988 Suicide & Crisis Lifeline and emergency resources
1
. Users can log sleep, movement, and mood to identify trends over time, creating a comprehensive view of their health patterns1
.The platform integrates health data from popular wearables including Apple Watch, Samsung Galaxy Watch, WHOOP, and Oura Ring, allowing users to view activity, sleep, and other metrics in one centralized location
1
2
. As understanding of wearables data utility grows, DataMeds AI anticipates providing more personalized insights based on users' health profiles1
.Related Stories
Users can purchase products marketed by Corexa Health's pharmacy directly in the app, including Tollo Health's proprietary medical food Forzet, indicated for the dietary management of muscle loss associated with weight loss therapies and available without a prescription
1
. The pharmacy also markets Tollo Health's antiviral products Galectovid, indicated for the dietary management of Galectin 1 & 3 associated viral infections, and 3CL protease inhibitor cleansing dietary supplement Tollovid, both available without a prescription1
.Through DataMeds' acquisition of Helomics Corporation, the app will soon offer direct-to-consumer lab tests available where permitted by law, with options for in-home or at-the-pharmacy sample collection
1
2
. Looking ahead, DataMeds aims to introduce digital twin capabilities and a proprietary blockchain option by 2027, granting users greater control over their health data2
. Gerald Commissiong, Interim Co-CEO of DataMeds, emphasized the company's vision: "What patients really want is for healthcare to be as easy to use as the apps they rely on every day. Health Lives Here gives patients one front door to telehealth, their local pharmacist and their own health data, and with NFL Alumni Health, we have messengers who can meet people where they are, including in rural and underserved communities"1
2
. Brad Edwards, CEO of the NFL Alumni Association, expressed excitement about helping DataMeds and Tollo Health launch Health Lives Here, especially to improve healthcare access for patients in rural communities1
.Summarized by
Navi
16 Sept 2026•Business and Economy

15 Jul 2026•Health
07 May 2025•Health

1
Technology

2
Technology

3
Policy and Regulation
